Bio Path reported $-976K in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -6.26M 1.52M Dec/2025
Baxter International USD 362M 368M Jun/2026
Bio Path USD -976K 3.62M Sep/2025
Cipla INR 10.82B 3.33B Jun/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -7.66M 64.51M Mar/2026
CSL USD 2.61B 1.21B Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026